Press-center

  • 09 April 2020

    ARPM: pharmaceutical industry mobilized to fight COVID-19

    Russia is doing everything possible to curb the spread of COVID-19. At this difficult time, the leading pharmaceutical companies unite and direct all their efforts to the creation and production of medicines and vaccines that everyone needs so much now. The pharmaceutical industry takes all necessary steps to maintain production continuity and ensure uninterrupted supply of medicines for patients both in Russia and the EAEU countries, and in countries that have applied for help to Russia.

  • Velfarm is a member of the Association of Russian Pharmaceutical Manufacturers 06 April 2020

    Velfarm is a member of the Association of Russian Pharmaceutical Manufacturers

    The Association of Russian pharmaceutical manufacturers is replenishing its ranks. In accordance with the decision of the ARPM general meeting, the company Velpharm LLC (BRIGHT WAY group of companies) became a new member. The company noted that they are optimistic about joining the ranks of the Association, which unites leading Russian pharmaceutical companies.
    Velfarm LLC is a Russian full-cycle pharmaceutical manufacturer that creates modern, effective, safe and affordable medicines.

  • 23 March 2020

    100 days before collapse

    Labeling of medicines is one of the most ambitious and discussed issues in the pharmaceutical industry. The entire pharmaceutical industry supports its introduction, but during the experiment, participants are faced with many problems that perplex not only the performers, but also the organizers of the project. In particular, manufacturers do not understand how to deal with a pandemic. Foreign specialists cannot come to production facilities for commissioning of the equipment, and Russian specialists cannot go abroad for testing and training. How do the experiment participants feel 100 days before the official launch of the drug labeling project?

  • Will coronavirus send labeling to quarantine? 19 March 2020

    Will coronavirus send labeling to quarantine?

    The Association of Russian Pharmaceutical Manufacturers sent a letter addressed to the Chairman of the State Duma of the Russian Federation Vyacheslav Volodin with a request to introduce a stop time for the period of restrictive quarantine measures for the introduction of drug labeling from July 1.
    Manufacturers contact the Association because of difficulties encountered in preparing for the launch of the mandatory drug labeling system.

  • ARPM: no need to escalate the situation 16 March 2020

    ARPM: no need to escalate the situation

    Prime Minister Mikhail Mishustin instructed to expedite the adoption of a bill that allows the remote sale of OTC (over-the-counter) drugs and their delivery due to an increase in the number of patients with coronavirus in the country. The State Duma may pass the law on selling drugs on the Internet on Thursday, March 19, Andrei Isaev, the first deputy head of the United Russia faction in the State Duma, announced this to REGNUM.

  • The common drug market in the EAEU is in the center of attention of pharmaceutical industry experts 12 March 2020

    The common drug market in the EAEU is in the center of attention of pharmaceutical industry experts

    “The functioning of the unified market for medicines of the Eurasian Economic Union” is the topic of a round table that will be held on April 7 as part of the XII scientific-practical conference “State regulation and the pharmaceutical industry”. The main issues of law enforcement requiring priority attention will be discussed by representatives of the EEC and authorized bodies of the countries of the Eurasian Economic Union with leading experts in the pharmaceutical industry.

  • We still have 116 days left ?! 05 March 2020

    We still have 116 days left ?!

    Starting March 1, all participants must be registered in the state drug movement monitoring (DMM) system. It is assumed that their information systems are already on alert for interaction with the state information system "DMM". To date, the most prepared link in the entire distribution chain are pharmaceutical manufacturers. But in the industry, there are still representatives of pharmacies and medical institutions who ask: what is labeling? Meanwhile, 116 days are left before the start. July 1, 2020 the law comes into force.

  • Interchangeability in Russia was, is and will be 02 March 2020

    Interchangeability in Russia was, is and will be

    The round table “Interchangeability of medicines” was held on the initiative of the Association of Russian Pharmaceutical Manufacturers in the press center of the publishing house “Komsomolskaya Pravda”. The discussion of the amendments adopted at the end of 2019 in 61-FL “On Circulation of Medicines” was joined by: the Federal Antimonopoly Service, the medical and patient communities, manufacturers and market experts. All parties have their own questions to the implementation of the rule of law.

  • 47 regions are on the track. Are “pilots” ready ?! 20 February 2020

    47 regions are on the track. Are “pilots” ready ?!

    Health issues come to the fore in the context of the goals and objectives of the development of our country. According to the order of the President of the Russian Federation Vladimir Putin, by July 1, 2020, the government needs to submit methodological proposals for a pilot project. Today, at the federal level, there is no understanding of how drug reimbursement models will be implemented. There are several suggestions, but there is no final decision as to which drug reimbursement system will be implemented, and there are no legal acts.

  • ARPM: 10 directions of pharmaceutical industry development 14 February 2020

    ARPM: 10 directions of pharmaceutical industry development

    February is the time to set goals for the coming year. The Director General of the Association of Russian Pharmaceutical Manufacturers Victor Dmitriev summed up the results of 2019, announced plans and dreams for 2020 at the meeting of the Russian Association of Pharmaceutical Marketing (RAPM). Welcoming the audience, the head of the ARPM noted that "it is impossible to change the past, but to draw conclusions, to analyze errors is simply necessary."

  • ARPM: are people behind the numbers or what is hidden behind the targets? 27 January 2020

    ARPM: are people behind the numbers or what is hidden behind the targets?

    In 2020, the national regime regarding the procurement of goods, work, services does not apply to products from the EAEU countries (Belarus, Kazakhstan, Armenia, Kyrgyzstan). Products from these states are not equivalent to foreign products under the national regime. These measures are designed to simplify and maintain the share of EAEU goods at the level of 50%. The government prepared the relevant amendments in 44-FL “On the contract system”. National regime includes preferences, restrictions and prohibitions. So, according to the new rules, it is forbidden to purchase foreign products for the defense and security of the country, but otherwise the “Third Extra” mechanism and price preferences will be applied.

  • "Regulatory guillotine" of alcohol-containing medicines was launched 21 January 2020

    "Regulatory guillotine" of alcohol-containing medicines was launched

    On January 17, a meeting of a working group from the expert and business community on the implementation of the “regulatory guillotine” in the production and turnover of alcoholic beverages took place. Ilya Lomakin-Rumyantsev, Director of the Center for Consumer Market Development at the Moscow School of Management Skolkovo, was elected Chairman of the working group. Olga Pentegova, Deputy Director General of the Association of Russian Pharmaceutical Manufacturers, represents the pharmaceutical industry.

  • ARPM Strategic Plans and Hot Topics for Today 11 December 2019

    ARPM Strategic Plans and Hot Topics for Today

    The transition period for the implementation of drug labeling will be extended by six months. “Medicinal products for medical use manufactured before July 1, 2020 are subject to storage, transportation, dispensing, sale, transfer, use without identification means until the expiration date,” the document says. The amendment adopted in the second reading allows participants in the process to register, test the system and debug business processes. In November, according to Elena Kudryavtseva, deputy head of the Office for Organization of State Quality Control of Medical Products of Federal Service for Surveillance in Healthcare (Roszdravnadzor), the industry’s readiness was 30%...

  • Denis Chetverikov, President of Akrikhin, was elected Chairman of the ARPM Supervisory Board 06 December 2019

    Denis Chetverikov, President of Akrikhin, was elected Chairman of the ARPM Supervisory Board

    On December 4, the annual General Meeting of the Association of Russian Pharmaceutical Manufacturers was held. The event was attended by the leaders of the ARPM member companies, representatives of state authorities, and pharmaceutical market experts.
    Denis Chetverikov, President of Akrikhin, was unanimously elected Chairman of the ARPM Supervisory Board. In his welcoming speech, he thanked his colleagues for their trust and noted that the member companies of the Association are key investors ...

  • Industry readiness for labeling as average hospital temperature 22 November 2019

    Industry readiness for labeling as average hospital temperature

    The Association of Russian Pharmaceutical Manufacturers held a round table “General preparedness for drug labeling” as part of the business program of the Pharmtech & Ingredients 2019 exhibition. The panelists once again discussed the degree of readiness of the industry to launch a drug movement monitoring system (DMM), gave an analysis of the first steps of labeling according to the program, 7 high-cost nosologies and identified problems that need to be addressed.

  • Restart or false start: what scenario will the deputies choose? 19 November 2019

    Restart or false start: what scenario will the deputies choose?

    Deputies submitted a bill to the State Duma of the Russian Federation on the phased implementation of drug labeling until July 1, 2020. The text of document No. 834261–7 is published on the portal of draft legal acts. 64 deputies and 3 members of the Federation Council have already joined the initiative.
    The bill says that “medicinal products for medical use intended to provide people with hemophilia, cystic fibrosis, pituitary dwarfism, Gaucher disease, malignant neoplasms of lymphoid, hematopoietic and and related tissues, multiple sclerosis, people after transplantation of organs ...

  • Marking: let's bring positions closer 31 October 2019

    Marking: let's bring positions closer

    “There will be no postponement of labeling unless force majeure occurs,” said Irina Golovina, Deputy Director General of the Federal State Budget Institution Information and methodological center for examination, accounting and analysis of circulation of medical devices of Federal Service for Surveillance in Healthcare (Roszdravnadzor), on the sidelines of the pharmaceutical industry digitalization forum on October 28 at the First Sechenov Moscow State Medical University. But at least three such cases have already occurred during the experiment. What the regulator calls force majeure is perceived by business as a hoax!

  • What is happening on the pharmaceutical market of Russia or again about labeling 11 October 2019

    What is happening on the pharmaceutical market of Russia or again about labeling

    On January 1, the drug labeling system in Russia will become mandatory for all market participants, without exception. Every day there is less and less time left until the start, and more questions arise. At round tables, meetings and forums the progress of the experiment and the readiness to implement the system are being discussed. Problems and forecasts were discussed at the international conference “What is happening on the pharmaceutical market”.

  • Labeling: going to the finish line 02 October 2019

    Labeling: going to the finish line

    From October 1, drugs used in the treatment of rare diseases (7 High cost nosologies) should be labeled. On the eve the head of Roszdravnadzor Mikhail Murashko said: “The entire infrastructure is assembled, the final product is being accepted. All organizations and all manufacturers of 28 drugs are connected to the system, all are registered. ”
    Drug labeling is the number one pharmaceutical industry topic. Manufacturers, distributors, pharmacies report their readiness, express concerns. The data of the regulator and the Center for development of advanced technologies are sometimes diametrically opposed to the participants in the process. So what is going on at the finish line?

  • ARPM: It's Time to Change the Paradigm of Presumption of Guilty Customer 01 October 2019

    ARPM: It's Time to Change the Paradigm of Presumption of Guilty Customer

    Partnering session “Modernization of the pharmaceutical health sector at the regional level. Features of the drug supply system in the regions of Russia ”was held as part of the IV All-Russian GMP conference with international participation in Svetlogorsk.
    The Association of Russian Pharmaceutical Manufacturers together with the Ministry of Health of the Kaliningrad Region, leading representatives of the pharmaceutical industry addressed urgent issues and prepared constructive proposals for the formation and implementation of a national drug policy.


News 1 - 20 from 200
First page | Prev. | 1 2 3 4 5 | Next | Last page